Global Biopharmaceutical Analytical Testing Services Market

Biopharmaceutical Analytical Testing Services Market Size, Share, Growth Analysis, By End-User(Pharma Companies & Biotechnology Companies, CROs), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2168 | Region: Global | Published Date: April, 2024
Pages: 249 | Tables: 35 | Figures: 74

Biopharmaceutical Analytical Testing Services Market Insights

Biopharmaceutical Analytical Testing Services Market size was valued at USD 7.58 Billion in 2019 and is poised to grow from USD 8.06 Billion in 2023 to USD 13.2 Billion by 2031, at a CAGR of 6.36% during the forecast period (2024-2031).

The classification of proteins and other compounds is a major factor of success in biopharmaceutical development. Molecular understandings obtained by analytical methods guide the complete drug discovery and development process, from applicant monitoring studies to bioprocess optimization and drug release testing. Complex analytical technologies are important for answering questions about the structure and activity of complex biotherapeutics and related impurities. To meet the growing needs across biopharmaceutical R&D, a wide variety of analytical tools continue to develop. Analytical techniques are used to detect capable drug targets and candidates with the highest therapeutic potential.

The outbreak had a negative impact on the analytical testing services market in the region. A rise in the number of COVID cases led to the imposition of partial lockdowns in several countries, including Canada and Mexico. Although, lockdown restrictions in various countries were lifted to some extent in the second half of 2020, which allowed the movement of people and led to the continuation of laboratory work. Therefore, the reopening of life sciences services will drive the demand for biopharmaceutical analytical testing services in North America, which, in turn, will drive the regional Biopharmaceutical Analytical Testing Services Market during the forecast period.

US Biopharmaceutical Analytical Testing Services Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biopharmaceutical Analytical Testing Services Market size was valued at USD 7.58 Billion in 2019 and is poised to grow from USD 8.06 Billion in 2023 to USD 13.2 Billion by 2031, at a CAGR of 6.36% during the forecast period (2024-2031).

The Global Biopharmaceutical Analytical Testing Services Market is highly competitive, with the existence of numerous major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve Biopharmaceutical Analytical Testing Services Market share and profitability. Some of the major players in the market are OptimoRoute Inc, Alphabet Inc, Wise Systems Inc, and Caliper Corp among others who are driving the Biopharmaceutical Analytical Testing Services Market. 'Eurofins Scientific (Luxembourg)', 'Charles River Laboratories International, Inc. (US)', 'SGS SA (Switzerland)', 'Merck KGaA (Germany)', 'Lonza Group Ltd. (Switzerland)', 'PPD, Inc. (US)', 'WuXi AppTec Co., Ltd. (China)', 'BioReliance Corporation (US)', 'Toxikon Corporation (US)', 'Almac Group (UK)', 'Avista Pharma Solutions (US)', 'Catalent, Inc. (US)', 'Source Bioscience (UK)', 'Intertek Group plc (UK)', 'Envigo (US)', 'ICON plc (Ireland)', 'LGC Limited (UK)', 'Sartorius AG (Germany)', 'Syneos Health (US)', 'Pace Analytical Services, LLC (US)'

One of the key factors for the growth of the biopharmaceutical analytical tests services market is the increase in demand for Methyl Methacrylate Acrylonitrile Butadiene Styrene. The global acrylonitrile methyl methacrylate market is growing as it is used for immunotherapy to boost immune responses for the treatment of diseases. R & D for antibodies for diseases like rheumatoid arthritis and cancers is carried out. Cancer is split at the swelling spot to provide targeted treatments.

The increasing investments in the R&D of the biopharmaceutical analytical testing services market are expected to have a positive influence in the coming years. The overheads on R&D are increased by 3.21% in 2021. Developing countries rising faster than that developed economies suggest that, these are expected to have an increased number of laboratories and research facilities during the forecast period.

In 2021, North America dominated the Biopharmaceutical Analytical Testing Services Market with a market share of more than 30%. The US and Canada are the the largest revenue contributing countries in the region as stable economies and infrastructure support the launch of new biopharmaceuticals. Market growth in this region will be faster than the growth of the Biopharmaceutical Analytical Testing Services Market in the European, MEA, and South American regions. This will facilitate the biopharmaceutical analytical testing services market growth over the forecast period. The Asia Pacific and European regions will witness the highest growth in the near future.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biopharmaceutical Analytical Testing Services Market

Report ID: SQMIG35H2168

$5,300
BUY NOW GET FREE SAMPLE